Vermillion, Inc.

12117 Bee Caves Rd, Austin, TX 78738

Public
Healthcare & Pharmaceuticals - Medical Devices
around $5 - 10M
around 50 - 100
(512) 519-0400
(512) 439-6980


Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evalu... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Vermillion, Inc.?


21 Contacts at this company
Valerie Palmieri
Chief Executive Officer
Melissa Bryant
Regional Business Director ? Mid-Atlantic ...
Karen de Loys
Specialty Development Executive ...
Daniel Larson
Business Development Manager
Emily Granger
Director of Marketing
Roger Burt
IT Development Director
Carla Phipps
Quality Assurance Manager
Dennis Wardell
Engineering Manager
Christine Yip
Senior Research Scientist

Dec 27, 2017 23:21:24
AUSTIN, Texas, Dec. 19, 2017 /PRNewswire/ -- Vermillion, Inc. (NASDAQ:  VRML), a bio-analytical solutions company focused on gynecologic disease, today announced it has appointed Bob Beechey CPA to the newly [...]

Aug 31, 2017 21:37:07
AUSTIN, Texas, Aug. 31, 2017 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML) will launch Ovarian Cancer Awareness Month by ringing the opening bell on Friday, September 1, joined by [...]

Aug 9, 2017 20:43:21
AUSTIN, Texas, Aug. 9, 2017 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for the second quarter ended [...]

Aug 4, 2017 20:43:18
AUSTIN, Texas, Aug. 4, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will now report its second quarter [...]

Aug 1, 2017 20:31:00
AUSTIN, Texas, Aug. 1, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri, President and Chief Executive Officer, [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.